NCT02032849

Brief Summary

This is a randomized controlled trial compared two methods to drainage subglottic secretion in prolonged intubated patients.After enrolled, patients are randomized assigned to intermittent subglottic secretion drainage group and air-impingement manipulation group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 10, 2014

Completed
22 days until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

August 15, 2014

Status Verified

August 1, 2014

Enrollment Period

2.3 years

First QC Date

December 30, 2013

Last Update Submit

August 13, 2014

Conditions

Keywords

ventilator associated pneumoniasubglottic secretion drainagemanual air-impingement operationprolonged intubation

Outcome Measures

Primary Outcomes (1)

  • Percentage of participants with ventilator-associated pneumonia

    Up to 28 days

Secondary Outcomes (1)

  • ICU mortality

    Participants will be followed for the duration of ICU stay, an expected average of 4 weeks

Other Outcomes (1)

  • Invasive ventilation duration

    Participants will be followed for the duration of invasive ventilation, an expected average of 7-10 days

Study Arms (2)

subglottic secretion drainage

ACTIVE COMPARATOR

The conventional method with a special tube to drainage subglottic secretion

Procedure: Manual air-impingement operation

Manual air-impingement operation

EXPERIMENTAL

A method which we invented to clear subglottic secretion

Device: subglottic secretion drainage

Interventions

A method which we invented to clear subglottic secretion

subglottic secretion drainage

The conventional method with a special tube to drainage subglottic secretion

Manual air-impingement operation

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Should meet all the criteria:
  • Intubation less than 24 hours before admitting respiratory intensive care unit;
  • Anticipated intubation for more than 72 hours;
  • Anticipated survival time is more than 2 weeks

You may not qualify if:

  • Meet any of these criteria:
  • PEEP≥10cmH2O or FiO2≥0.8;
  • unstable hemodynamics;
  • severe bulla and pneumothorax;
  • enrolled in other study;
  • cuff leak test is positive.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Chaoyang hospital

Beijing, Beijing Municipality, 100020, China

RECRUITING

Related Publications (1)

  • Li Y, Yuan X, Sun B, Li HC, Chu HW, Wang L, Zhao Y, Tang X, Wang R, Li XY, Tong ZH, Wang C. Rapid-flow expulsion maneuver in subglottic secretion clearance to prevent ventilator-associated pneumonia: a randomized controlled study. Ann Intensive Care. 2021 Jun 24;11(1):98. doi: 10.1186/s13613-021-00887-5.

MeSH Terms

Conditions

Pneumonia, Ventilator-Associated

Condition Hierarchy (Ancestors)

Healthcare-Associated PneumoniaCross InfectionInfectionsPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jie Li, Master

    Beijing Chao Yang Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RRT-NPS

Study Record Dates

First Submitted

December 30, 2013

First Posted

January 10, 2014

Study Start

February 1, 2014

Primary Completion

June 1, 2016

Study Completion

December 1, 2016

Last Updated

August 15, 2014

Record last verified: 2014-08

Locations